Phase III IMvoke010 trial found that maintenance treatment with Tecentriq (atezolizumab) did not significantly improve ...
Jiangsu Hengrui Pharmaceuticals and its partner Elevar Therapeutics will have to wait even longer before their PD-1 inhibitor ...
News Medical on MSN23h
Review explores the underlying mechanisms of hepatocarcinogenesis post-HCV eradicationHepatitis C virus (HCV) infection remains a major global health burden, affecting millions worldwide and contributing significantly to hepatocellular carcinoma (HCC) development.
Despite resubmitting after an initial complete response letter (CRL) due to manufacturing issues, the combination therapy ...
A research team led by Sheri Holmen, Ph.D., investigator at Huntsman Cancer Institute and professor in the Department of ...
Charlotte Elwood was diagnosed with a rare ovarian cancer in 1997 and given six months to live. She received multiple ...
News-Medical.Net on MSN22h
Cleveland Clinic study reveals insights on immune checkpoint inhibitors for colorectal cancerA team of researchers from Cleveland Clinic Genomic Medicine share insights from an early set of 19,000 patients to receive immune checkpoint inhibitor treatments for colorectal cancer in the U.S.
For patients with chronic liver disease, statin use is associated with reduced risk for hepatocellular carcinoma and hepatic decompensation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback